Cargando…

Effect of Acupoint Catgut Embedding for Abdominally Obese Female with Strong Appetite: Mixed Analysis of a Randomized Clinical Trial

BACKGROUND: Abdominal obesity (AO) is not only a health issue, but also a serious impact on women’s work and life. The article of acupoint catgut embedding (ACE) on AO has already been accepted to be published and showed significant effect. However, whether ACE is effective for abdominally obese fem...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinghe, Li, Qifu, Yi, Rong, Xing, Chonghui, Jin, Yuhao, Meng, Jiangqiong, Zhao, Siwen, Liang, Fanrong, Guo, Taipin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635479/
https://www.ncbi.nlm.nih.gov/pubmed/36341230
http://dx.doi.org/10.2147/DMSO.S388485
_version_ 1784824725839544320
author Zhang, Xinghe
Li, Qifu
Yi, Rong
Xing, Chonghui
Jin, Yuhao
Meng, Jiangqiong
Zhao, Siwen
Liang, Fanrong
Guo, Taipin
author_facet Zhang, Xinghe
Li, Qifu
Yi, Rong
Xing, Chonghui
Jin, Yuhao
Meng, Jiangqiong
Zhao, Siwen
Liang, Fanrong
Guo, Taipin
author_sort Zhang, Xinghe
collection PubMed
description BACKGROUND: Abdominal obesity (AO) is not only a health issue, but also a serious impact on women’s work and life. The article of acupoint catgut embedding (ACE) on AO has already been accepted to be published and showed significant effect. However, whether ACE is effective for abdominally obese female with strong appetite is still unclear. METHODS: This is a mixed analysis of a multicenter, double-blind, randomized controlled trial.Which was conducted in China between July 2018 and March 2020 (n = 101), while with the supplementary samples (n = 22) between April 2020 and June 2022. According to the appetite and intervention methods, 123 abdominally obese female were divided into ACE group with strong appetite (n = 27) and moderate appetite (n = 31), control (non-acupoint catgut embedding) group with strong appetite (n = 37) and moderate appetite (n = 28). Four subgroups were given a 12-week actual intervention period and a 4-week follow-up. Waist circumference (WC), appetite, body weight and BMI were applied and assessed at baseline and after 6, 12 and 16 weeks. RESULTS: In this study, the mean onset age of abdominal obesity in females was 25.27 (8.19) years old. The longer duration of AO, the lower the appetite in females (p<0.05). At 12 and 16 weeks, ACE group with strong appetite showed significant decrease in WC and appetite than control group with strong appetite (p<0.01). However, ACE group with moderate appetite showed no significant decrease than control group with moderate appetite in WC, appetite, body weight and BMI (p>0.05). At 12 and 16 weeks, there was no significant difference in appetite between the ACE groups (strong and moderate appetite)(p>0.05), while there was still a difference between the control groups (p<0.05). CONCLUSION: Younger abdominally obese female had a stronger appetite. ACE own the remarkable therapeutic effects for younger abdominally obese female and showed the perfect effect on appetite-reduction.
format Online
Article
Text
id pubmed-9635479
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-96354792022-11-05 Effect of Acupoint Catgut Embedding for Abdominally Obese Female with Strong Appetite: Mixed Analysis of a Randomized Clinical Trial Zhang, Xinghe Li, Qifu Yi, Rong Xing, Chonghui Jin, Yuhao Meng, Jiangqiong Zhao, Siwen Liang, Fanrong Guo, Taipin Diabetes Metab Syndr Obes Original Research BACKGROUND: Abdominal obesity (AO) is not only a health issue, but also a serious impact on women’s work and life. The article of acupoint catgut embedding (ACE) on AO has already been accepted to be published and showed significant effect. However, whether ACE is effective for abdominally obese female with strong appetite is still unclear. METHODS: This is a mixed analysis of a multicenter, double-blind, randomized controlled trial.Which was conducted in China between July 2018 and March 2020 (n = 101), while with the supplementary samples (n = 22) between April 2020 and June 2022. According to the appetite and intervention methods, 123 abdominally obese female were divided into ACE group with strong appetite (n = 27) and moderate appetite (n = 31), control (non-acupoint catgut embedding) group with strong appetite (n = 37) and moderate appetite (n = 28). Four subgroups were given a 12-week actual intervention period and a 4-week follow-up. Waist circumference (WC), appetite, body weight and BMI were applied and assessed at baseline and after 6, 12 and 16 weeks. RESULTS: In this study, the mean onset age of abdominal obesity in females was 25.27 (8.19) years old. The longer duration of AO, the lower the appetite in females (p<0.05). At 12 and 16 weeks, ACE group with strong appetite showed significant decrease in WC and appetite than control group with strong appetite (p<0.01). However, ACE group with moderate appetite showed no significant decrease than control group with moderate appetite in WC, appetite, body weight and BMI (p>0.05). At 12 and 16 weeks, there was no significant difference in appetite between the ACE groups (strong and moderate appetite)(p>0.05), while there was still a difference between the control groups (p<0.05). CONCLUSION: Younger abdominally obese female had a stronger appetite. ACE own the remarkable therapeutic effects for younger abdominally obese female and showed the perfect effect on appetite-reduction. Dove 2022-10-31 /pmc/articles/PMC9635479/ /pubmed/36341230 http://dx.doi.org/10.2147/DMSO.S388485 Text en © 2022 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Xinghe
Li, Qifu
Yi, Rong
Xing, Chonghui
Jin, Yuhao
Meng, Jiangqiong
Zhao, Siwen
Liang, Fanrong
Guo, Taipin
Effect of Acupoint Catgut Embedding for Abdominally Obese Female with Strong Appetite: Mixed Analysis of a Randomized Clinical Trial
title Effect of Acupoint Catgut Embedding for Abdominally Obese Female with Strong Appetite: Mixed Analysis of a Randomized Clinical Trial
title_full Effect of Acupoint Catgut Embedding for Abdominally Obese Female with Strong Appetite: Mixed Analysis of a Randomized Clinical Trial
title_fullStr Effect of Acupoint Catgut Embedding for Abdominally Obese Female with Strong Appetite: Mixed Analysis of a Randomized Clinical Trial
title_full_unstemmed Effect of Acupoint Catgut Embedding for Abdominally Obese Female with Strong Appetite: Mixed Analysis of a Randomized Clinical Trial
title_short Effect of Acupoint Catgut Embedding for Abdominally Obese Female with Strong Appetite: Mixed Analysis of a Randomized Clinical Trial
title_sort effect of acupoint catgut embedding for abdominally obese female with strong appetite: mixed analysis of a randomized clinical trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635479/
https://www.ncbi.nlm.nih.gov/pubmed/36341230
http://dx.doi.org/10.2147/DMSO.S388485
work_keys_str_mv AT zhangxinghe effectofacupointcatgutembeddingforabdominallyobesefemalewithstrongappetitemixedanalysisofarandomizedclinicaltrial
AT liqifu effectofacupointcatgutembeddingforabdominallyobesefemalewithstrongappetitemixedanalysisofarandomizedclinicaltrial
AT yirong effectofacupointcatgutembeddingforabdominallyobesefemalewithstrongappetitemixedanalysisofarandomizedclinicaltrial
AT xingchonghui effectofacupointcatgutembeddingforabdominallyobesefemalewithstrongappetitemixedanalysisofarandomizedclinicaltrial
AT jinyuhao effectofacupointcatgutembeddingforabdominallyobesefemalewithstrongappetitemixedanalysisofarandomizedclinicaltrial
AT mengjiangqiong effectofacupointcatgutembeddingforabdominallyobesefemalewithstrongappetitemixedanalysisofarandomizedclinicaltrial
AT zhaosiwen effectofacupointcatgutembeddingforabdominallyobesefemalewithstrongappetitemixedanalysisofarandomizedclinicaltrial
AT liangfanrong effectofacupointcatgutembeddingforabdominallyobesefemalewithstrongappetitemixedanalysisofarandomizedclinicaltrial
AT guotaipin effectofacupointcatgutembeddingforabdominallyobesefemalewithstrongappetitemixedanalysisofarandomizedclinicaltrial